Follow this preprint
Serological responses to COVID-19 booster vaccine in England
Georgina Ireland, Heather Whitaker, Shamez N Ladhani, Frances Baawuah, Vani Subbarao, Ezra Linley, Lenesha Warrener, Michelle O’Brien, Corinne Whillock, Paul Moss, Mary E Ramsay, Gayatri Amirthalingam, Kevin E Brown
doi: https://doi.org/10.1101/2021.11.22.21266692
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Georgina Ireland
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
Heather Whitaker
2Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom
Shamez N Ladhani
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
7Paediatric Infectious Diseases Research Group, St. George’s University of London, London, United Kingdom
Frances Baawuah
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
3Brondesbury Medical Centre, Kilburn, London, United Kingdom
Vani Subbarao
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
Ezra Linley
4Sero-Epidemiology Unit, UK Health Security Agency, Manchester, United Kingdom
Lenesha Warrener
5Virus Reference Department, UK Health Security Agency, London, United Kingdom
Michelle O’Brien
3Brondesbury Medical Centre, Kilburn, London, United Kingdom
Corinne Whillock
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
Paul Moss
6Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom
Mary E Ramsay
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
Gayatri Amirthalingam
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
Kevin E Brown
1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom

Posted November 24, 2021.
Serological responses to COVID-19 booster vaccine in England
Georgina Ireland, Heather Whitaker, Shamez N Ladhani, Frances Baawuah, Vani Subbarao, Ezra Linley, Lenesha Warrener, Michelle O’Brien, Corinne Whillock, Paul Moss, Mary E Ramsay, Gayatri Amirthalingam, Kevin E Brown
medRxiv 2021.11.22.21266692; doi: https://doi.org/10.1101/2021.11.22.21266692
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
8
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3086)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4834)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3057)
- Health Policy (1101)
- Hematology (410)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4606)
- Nursing (244)
- Nutrition (684)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1239)
- Primary Care Research (520)
- Public and Global Health (7189)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (221)
- Urology (189)